Deutsche Bank analyst George Hill raised the firm’s price target on UnitedHealth to $562 from $545 and keeps a Buy rating on the shares. The company reported a Q1 earnings beat with many moving pieces caused by the cyberattack on Change Healthcare, which left earnings quality and guidance up to investor interpretation, the analyst tells investors in a research note. The firm sees the full impact of the hack, as well as conservatism around cost trend and utilization would impact UnitedHealth earnings by only 2% for the full year.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- Thursday Macro & Markets Update – 04.18.24
- Early notable gainers among liquid option names on April 17th
- UnitedHealth price target lowered to $555 from $596 at RBC Capital
- UnitedHealth price target raised to $571 from $566 at Piper Sandler
- UnitedHealth price target raised to $560 from $534 at Barclays